Page 3 - Hygiene Unit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Trial to assess antimicrobial nasal spray in treating mild COVID-19 4 The study will assess whether APR-AOS2020 can reduce the viral load of recently infected COVID-19 patients with mild symptoms. Investigators have initiated a study to evaluate the efficacy of APR-AOS2020, a novel nasal spray, in the treatment of COVID-19 patients showing mild symptoms. The study, co-ordinated by lead investigator Professor Giancarlo Icardi, will enrol 57 COVID-19 patients at the Hygiene Unit of IRCCS Policlinico San Martino Hospital in Genoa, Italy. The trial will asses the efficacy and safety of the spray ...

Share this article Product recently cleared in EU as Class III medical device BALERNA, Switzerland, May 12, 2021 /PRNewswire/ -- APR Applied Pharma Research s.a. (APR), a leader in the development of pharmaceutical drug delivery technologies and systems and innovative products derived thereof, today announced the start of a pivotal clinical trial to assess the efficacy of its product temporarily codenamed APR-AOS2020, a Class III medical device, in the treatment of COVID-19 patients showing mild symptoms. The study is being conducted by the Hygiene Unit of IRCCS Policlinico San Martino Hospit...

Share this article Share this article BALERNA, Switzerland, May 12, 2021 /PRNewswire/ -- APR Applied Pharma Research s.a. (APR), a leader in the development of pharmaceutical drug delivery technologies and systems and innovative products derived thereof, today announced the start of a pivotal clinical trial to assess the efficacy of its product temporarily codenamed APR-AOS2020, a Class III medical device, in the treatment of COVID-19 patients showing mild symptoms. The study is being conducted by the Hygiene Unit of IRCCS Policlinico San Martino Hospital in Genoa, Italy and coordinated by Pr...

12 maggio 2021 16:52 Fonte: Adnkronos #salute-e-benessere Product recently cleared in EU as Class III medical device BALERNA, Switzerland, May 12, 2021 /PRNewswire/ -- APR Applied Pharma Research s.a. (APR), a leader in the development of pharmaceutical drug delivery technologies and systems and innovative products derived thereof, today announced the start of a pivotal clinical trial to assess the efficacy of its product temporarily codenamed APR-AOS2020, a Class III medical device, in the treatment of COVID-19 patients showing mild symptoms. The study is being conducted by the Hygiene Unit ...

IOM provides safe drinking water for flood-affected communities in Pibor, South Sudan Format Pibor – “Wait, so you mean to tell me that this water here is the same water coming out of that tap over there?” I ask in total amazement. "Well, yes. Kind of," says James Lagu, the International Organization for Migration’s (IOM) Water, Sanitation and Hygiene (WASH) Assistant Engineer in South Sudan. “It is the same water, but before the surface water reaches the taps, it undergoes various steps to make it safe for drinking,” he explains. James and I are at the Surface Water Treatment (SW...